News Medical7h
Vision loss risks in patients using popular GLP-1 medications raise concerns
A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a ...
New Atlas2d
Ozempic is suspected in more cases of sudden vision loss
Scientists remain puzzled as to why some individuals taking popular weight loss and diabetes medications such as Ozempic and ...
Endocrinology Advisor2d
Susvimo Approval Expanded to Include Diabetic Macular Edema
The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.
The Rogersville Review2d
FDA Approves Susvimo for Diabetic Macular Edema
The U.S. Food and Drug Administration has approved Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular edema.